Cargando…

Dose-tapering trajectories in patients with remitted psychosis undergoing guided antipsychotic reduction to reach minimum effective dose

BACKGROUND: Patients with remitted psychosis wish to reduce antipsychotic doses yet facing increased risks of relapse. Examining dose-tapering processes may provide insights to re-evaluate the risk-to-benefit balance. We aimed to depict and subgroup tapering trajectories, and explore factors associa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Chen-Chung, Hsieh, Ming H., Chien, Yi-Ling, Liu, Chih-Min, Lin, Yi-Ting, Hwang, Tzung-Jeng, Hwu, Hai-Gwo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594210/ https://www.ncbi.nlm.nih.gov/pubmed/37578111 http://dx.doi.org/10.1192/j.eurpsy.2023.2440

Ejemplares similares

Challenging the Minimum Effective Antipsychotic Dose During Maintenance: Implications From 10-Year Follow-Up of First Episode Psychosis
por: Liu, Chen-Chung, et al.
Publicado: (2021)

S122. TEN-YEAR FOLLOW-UP AFTER FIRST EPISODE PSYCHOSIS: FOCUSED ON LOW DOSE ANTIPSYCHOTIC MAINTENANCE AND FUNCTIONING
por: Liu, Chen-Chung, et al.
Publicado: (2020)

Auditory Event-Related Potentials in Antipsychotic-Free Subjects With Ultra-High-Risk State and First-Episode Psychosis
por: Hsieh, Ming H., et al.
Publicado: (2019)

Discontinuing Antipsychotic Medication After Remission from First-Episode Psychosis: A Survey of Psychiatrists’ Attitudes in Taiwan
por: Yen, Ko, et al.
Publicado: (2022)

T182. SHARED AND DISTINCT ALTERATIONS IN THE WHITE MATTER TRACTS OF REMITTED AND NON-REMITTED PATIENTS WITH SCHIZOPHRENIA
por: Hwang, Tzung-Jeng, et al.
Publicado: (2018)

S227. A PROPOSED ALTERNATIVE BETWEEN DISCONTINUATION AND MAINTENANCE OF ANTIPSYCHOTICS: A GUIDED DOSE REDUCTION TRIAL FOR PATIENTS WITH REMITTED PSYCHOSIS
por: Liu, Chen-Chung
Publicado: (2018)

Identifying dopamine supersensitivity through a randomized controlled study of switching to aripiprazole from other antipsychotic agents in patients with schizophrenia
por: Ma, Chia-Hao, et al.
Publicado: (2022)

Dose Reduction/Discontinuation of Antipsychotic Drugs in Psychosis; Effect on Cognition and Functional Outcomes
por: Omachi, Yoshie, et al.
Publicado: (2018)

Implementing gradual, hyperbolic tapering of long-acting injectable antipsychotics by prolonging the inter-dose interval: an in silico modelling study
por: O’Neill, James R., et al.
Publicado: (2023)

Hemispheric lateralization of semantic processing before and after aripiprazole treatment in first-episode psychosis or ultra-high risk state
por: Hwang, Tzung-Jeng, et al.
Publicado: (2022)

Frequency Dependent Alterations in Regional Homogeneity of Baseline Brain Activity in Schizophrenia
por: Yu, Rongjun, et al.
Publicado: (2013)

Differentiation of Schizophrenia Patients from Healthy Subjects by Mismatch Negativity and Neuropsychological Tests
por: Lin, Yi-Ting, et al.
Publicado: (2012)

A Diagnostic Model Incorporating P50 Sensory Gating and Neuropsychological Tests for Schizophrenia
por: Shan, Jia-Chi, et al.
Publicado: (2013)

A Systematic Review of the Need for Guideline Recommendations; Slow Tapering vs. Maintenance Dose in Long-Term Antipsychotic Treatment: 2022
por: Potla, Shanthi, et al.
Publicado: (2023)

Abnormally low prolactin levels in schizophrenia patients after switching to aripiprazole in a randomized trial: a biomarker for rebound in psychotic symptoms?
por: Jen, Ya-Wen, et al.
Publicado: (2020)

Antipsychotic dose reduction compared to dose continuation for people with schizophrenia
por: Rodolico, Alessandro, et al.
Publicado: (2022)

Dose Tapering of Biologics in Patients with Psoriasis: A Scoping Review
por: Michielsens, C. A. J., et al.
Publicado: (2021)

Comparison of antipsychotic dose equivalents for acute bipolar mania and schizophrenia
por: Yu, Chia-Ling, et al.
Publicado: (2023)

Antipsychotic Polypharmacy in Clozapine Resistant Schizophrenia: A Randomized Controlled Trial of Tapering Antipsychotic Co-treatment
por: Repo-Tiihonen, Eila, et al.
Publicado: (2012)

Discontinuation and dose reduction of rituximab in relapsing–remitting multiple sclerosis
por: Boremalm, Malin, et al.
Publicado: (2021)

S139. PROGRESSIVE DETERIORATION OF WHITE MATTER TRACTS IN SCHIZOPHRENIA: A DIFFUSION MRI STUDY ON A LARGE SINGLE COHORT USING NORMATIVE MODELS
por: Hwang, Tzung-Jeng, et al.
Publicado: (2020)

Detection of advanced brain aging in schizophrenia and its structural underpinning by using normative brain age metrics
por: Chen, Chang-Le, et al.
Publicado: (2022)

A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse
por: Horowitz, Mark Abie, et al.
Publicado: (2021)

High dose antipsychotic treatment monitoring audit
por: Scott, Jake, et al.
Publicado: (2021)

Tackling constipation in patients on high dose antipsychotics
por: Eappen, Sandhya
Publicado: (2021)

Choosing an Optimal Antipsychotic Dose for Relapse Prevention
por: Davis, John M, et al.
Publicado: (2022)

Is a minimum dose of atropine in children justified?
por: Prakash, Smita, et al.
Publicado: (2017)

The Importance of Choosing the Indicated Remedy in the Minimum Dose
por: Hood, F. C.
Publicado: (1890)

Antipsychotics for elderly with psychosis: Deprescribe or continue?
por: Mohr, P.
Publicado: (2021)

Niacin skin flush and membrane polyunsaturated fatty acids in schizophrenia from the acute state to partial remission: a dynamic relationship
por: Yu, Ya-Hui, et al.
Publicado: (2022)

Oral High-Dose Atorvastatin Treatment in Relapsing-Remitting Multiple Sclerosis
por: Paul, Friedemann, et al.
Publicado: (2008)

High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS
por: Nash, Richard A., et al.
Publicado: (2017)

Half-dose ocrelizumab in selected patients with relapsing–remitting multiple sclerosis
por: Algahtani, Hussein, et al.
Publicado: (2023)

PM390. Comparison of Fast Versus Slow Strategy in Switching Schizophrenia Patients to Aripiprazole from Other Antipsychotics
por: Hwang, Tzung-Jeng, et al.
Publicado: (2016)

Correction to: A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse
Publicado: (2022)

Determination of Optimal Doses and Minimum Effective Concentrations of Tricaine Methanesulfonate, 2-Phenoxyethanol and Eugenol for Laboratory Managements in Nile Tilapia (Oreochromis niloticus)
por: Rairat, Tirawat, et al.
Publicado: (2021)

Early corticosteroid dose tapering in patients with acute exacerbation of idiopathic pulmonary fibrosis
por: Anan, Keisuke, et al.
Publicado: (2022)

Dynamic visualization of ultraviolet dose on skin with sunscreen applied using minimum erythema dose
por: Li, Zhi, et al.
Publicado: (2022)

Population pharmacokinetics and dosing of long-acting injectable antipsychotics
por: Kim, David D., et al.
Publicado: (2021)

Sex differences for antipsychotic dosing and how to guide therapy
por: Schoretsanitis, G.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m4vliqsae8v9727khpivo8p43h